Study Assessing the Safety and Efficacy of Pegcetacoplan in Post-Transplant Recurrence of C3G or IC-MPGN
Status:
Recruiting
Trial end date:
2022-09-01
Target enrollment:
Participant gender:
Summary
This is a Phase 2, multicenter, open-label, randomized, controlled study designed to evaluate
the safety and efficacy of pegcetacoplan in patients who have post-transplant recurrence of
C3G or IC-MPGN.